Cargando…

No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions

Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Heald, Adrian H., Walther, Andreas, Davis, Julian R. E., Moreno, Gabriela Y. C., Kane, John, Livingston, Mark, Fowler, Helen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425479/
https://www.ncbi.nlm.nih.gov/pubmed/28553251
http://dx.doi.org/10.3389/fpsyg.2017.00764
_version_ 1783235308894027776
author Heald, Adrian H.
Walther, Andreas
Davis, Julian R. E.
Moreno, Gabriela Y. C.
Kane, John
Livingston, Mark
Fowler, Helen L.
author_facet Heald, Adrian H.
Walther, Andreas
Davis, Julian R. E.
Moreno, Gabriela Y. C.
Kane, John
Livingston, Mark
Fowler, Helen L.
author_sort Heald, Adrian H.
collection PubMed
description Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects of DHEA deficiency on energy level and mood. We measured emotional well-being in 16 patients with Addison’s disease and a group of 16 hospital attendees with type 2 diabetes. Participants completed the General Health Questionnaire-28 (GHQ-28), the Hospital Anxiety and Depression Scale (HADS), the World Health Organization’s quality of life assessment (WHOQOL-BREF) and the Holmes–Rahe life event scale. DHEA-S was low in Addison’s patients (Addison’s men: 0.5 ± 0.1 μmol/l [normal range: 2.1–10.8] compared with diabetes men: 3.2 ± 1.2 μmol/l; Addison’s women: 0.4 ± 0.01 μmol/l [normal range: 1.0–11.5] compared with diabetes women: 2.2 ± 0.71 μmol/l). Testosterone levels were similar in both groups studied. There were no differences in emotional well-being and quality of life (QOL) between patients with Addison’s disease and Type 2 Diabetes Mellitus as measured by GHQ-28 (Addison’s: 22.4 ± 2.6, Diabetes: 19.6 ± 2.7), HADS Depression (Addison’s: 5.4 ± 0.9, Diabetes: 4.5 ± 1.4), HADS Anxiety and WHOQOL-BREF. There were no gender differences in affective symptomatology within the Addison’s group. Life event scores were above average in both groups (Addison’s: 195 ± 39.6, Diabetes: 131 ± 43.8), but not significant for difference between groups as was GHQ-28 total score. Both groups scored highly on the GHQ-28 and the life event scale, indicative of poorer health perceptions than the general population. This could be due to the chronicity of both disorders. We have not identified any specific effects of DHEA-S deficiency on mood or QOL.
format Online
Article
Text
id pubmed-5425479
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54254792017-05-26 No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions Heald, Adrian H. Walther, Andreas Davis, Julian R. E. Moreno, Gabriela Y. C. Kane, John Livingston, Mark Fowler, Helen L. Front Psychol Psychology Patients with Addison’s disease have relatively high rates of depression and anxiety symptoms compared with population-based reference samples. Addison’s disease results in deficiency of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S). There is considerable debate about the specific effects of DHEA deficiency on energy level and mood. We measured emotional well-being in 16 patients with Addison’s disease and a group of 16 hospital attendees with type 2 diabetes. Participants completed the General Health Questionnaire-28 (GHQ-28), the Hospital Anxiety and Depression Scale (HADS), the World Health Organization’s quality of life assessment (WHOQOL-BREF) and the Holmes–Rahe life event scale. DHEA-S was low in Addison’s patients (Addison’s men: 0.5 ± 0.1 μmol/l [normal range: 2.1–10.8] compared with diabetes men: 3.2 ± 1.2 μmol/l; Addison’s women: 0.4 ± 0.01 μmol/l [normal range: 1.0–11.5] compared with diabetes women: 2.2 ± 0.71 μmol/l). Testosterone levels were similar in both groups studied. There were no differences in emotional well-being and quality of life (QOL) between patients with Addison’s disease and Type 2 Diabetes Mellitus as measured by GHQ-28 (Addison’s: 22.4 ± 2.6, Diabetes: 19.6 ± 2.7), HADS Depression (Addison’s: 5.4 ± 0.9, Diabetes: 4.5 ± 1.4), HADS Anxiety and WHOQOL-BREF. There were no gender differences in affective symptomatology within the Addison’s group. Life event scores were above average in both groups (Addison’s: 195 ± 39.6, Diabetes: 131 ± 43.8), but not significant for difference between groups as was GHQ-28 total score. Both groups scored highly on the GHQ-28 and the life event scale, indicative of poorer health perceptions than the general population. This could be due to the chronicity of both disorders. We have not identified any specific effects of DHEA-S deficiency on mood or QOL. Frontiers Media S.A. 2017-05-11 /pmc/articles/PMC5425479/ /pubmed/28553251 http://dx.doi.org/10.3389/fpsyg.2017.00764 Text en Copyright © 2017 Heald, Walther, Davis, Moreno, Kane, Livingston and Fowler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Heald, Adrian H.
Walther, Andreas
Davis, Julian R. E.
Moreno, Gabriela Y. C.
Kane, John
Livingston, Mark
Fowler, Helen L.
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title_full No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title_fullStr No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title_full_unstemmed No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title_short No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison’s Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These Conditions
title_sort no difference in mood and quality of life in dhea-s deficient adults with addison’s disease vs. type 2 diabetes patients with normal dhea-s levels: implications for management of these conditions
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425479/
https://www.ncbi.nlm.nih.gov/pubmed/28553251
http://dx.doi.org/10.3389/fpsyg.2017.00764
work_keys_str_mv AT healdadrianh nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT waltherandreas nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT davisjulianre nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT morenogabrielayc nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT kanejohn nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT livingstonmark nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions
AT fowlerhelenl nodifferenceinmoodandqualityoflifeindheasdeficientadultswithaddisonsdiseasevstype2diabetespatientswithnormaldheaslevelsimplicationsformanagementoftheseconditions